API PRODUCT LIST Banner

API PRODUCT

Back

Raltegravir

Therapeutic Category

TECHNICAL PROFILE

CAS No: 871038-72-1

Empirical formula: C20H20FKN6O5

Molecular weight: 482.51

 

 

 

 

ADVANTAGES

Raltegravir is an antiretroviral Active Pharmaceutical Ingredient (API) that inhibits HIV integrase. It is clinically used to treat the HIV infection and decrease infection rates by preventing insertion of HIV-1 DNA into the host genome. Raltegravir is the first-in-class integrase inhibitor.

 

BENEFITS

 

We offer raltegravir API manufactured using a non-infringing and competitive process with respect to the prior art in terms of raw material consumptions, atom and step economy.

The process was designed, developed and optimized in-house for lean and scalable manufacturing, providing an additional advantage for high-volume products such as Raltegravir.

We also offer advantageous and non-infringing crystalline form options, which enable early access to the European market.

 

 

Chemical structure of raltegravir

Products which are subject to patent protection are currently not offered or made available in countries where patents are in force. 
No orders or deliveries are possible prior to the expiry date of valid patents.

For inquiries, contact us on +30 2311 999960
or send us an email at info@viopharmaceuticals.com